Skip to main content
SpringerLink
Log in
Book cover

Hormonale Kontrazeption pp 1–20Cite as

Risikoanalyse der hormonalen Kontrazeption

  • Conference paper

  • 21 Accesses

Zusammenfassung

Im Hinblick auf die Anwendung kontrazeptiver Methoden ist es in der Zeit von 1970 bis 1980 zu deutlichen Veränderungen gekommen. Die hormonale Kontrazeption hat einen weiteren Aufschwung erfahren. Während noch 1970 etwa 30 Millionen Frauen die Pille zur Kontrazeption anwendeten, sind es zur Zeit 60–80 Millionen; insgesamt haben 150 Millionen Frauen bereits Erfahrung mit der hormonalen Kontrazeption. In den lateinamerikanischen Ländern sind mechanische Hilfen bei der Frau (Scheidendiaphragma) sowie Verhaltensmethoden mehr in den Vordergrund getreten. Das Intrauterinpessar konnte sich weltweit nur allmählich durchsetzen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Beral V, Ramcharan S, Fans R (1977): Malignant melanoma and oral contraceptive use among women in California. Brit J Cancer 36: 804–809

    Article  PubMed  CAS  Google Scholar 

  • Eser A, Hirsch HA (Hrsg.) (1980): Sterilisation und Schwangerschaftsabbruch. Enke Verlag, Stuttgart

    Google Scholar 

  • Jordan WM (1961): Pulmonary embolism. Lancet II 1146–1147

    Article  Google Scholar 

  • Grabowski MU, Stenram U, Bergqvist A (1975): Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver. Acta path microbiol scand Section A 83 615–622

    CAS  Google Scholar 

  • Hoover R, Bain C, Cole P, MacMahon B (1978): Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. Am J Public Health 68: 355–361

    Article  Google Scholar 

  • Mishell DR (1979): Oral Steroids, in: Reproductive Endocrinology, Infertility and Contraception, Davis Company, Philadelphia

    Google Scholar 

  • Morrison AS, Jick H, Ory HW (1977): Oral contraceptives and hepatitis. A report from the Boston Surveillance Program, Boston University Medical Center. Lancet I 1142–1143

    Article  Google Scholar 

  • Petitti DB, Wingerd J, Pelegrin F, Ramcharan S (1978): Oral contraceptives, smoking and other factors in relation to the risk of venous thromboembolic disease. Am J Epedem 108: 480–485

    CAS  Google Scholar 

  • Population Reports (1982): Oral Contraceptives: Oral contraceptives in the 1980s. Series A, Number 6, May-June. Population Information Program, The Johns Hopkins University, Baltimore, Maryland, USA.

    Google Scholar 

  • Rabe T, Runnebaum B (1982): Kontrazeption. Springer-Verlag, Berlin-Heidelberg-New York

    Google Scholar 

  • Ramcharan S, Pellegrin FA, Ray R, Hsu JP (1981): General description of the study; characteristics of the cohort; followup of the cohort. In: Ramcharan S, Pellegrin FA, Ray R and Hsu JP, The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives. Vol. 3. An interim report - a comparison of disease occurence leading to hospitalization or death of users and nonusers of oral contraceptives. Bethesda, Maryland, Center for Population Research, p. 1–26

    Google Scholar 

  • Royal College of General Practitioners (1974): Oral contraception and health; an interim report from the oral contraception study of the Royal College of General Practitioners. Pitman New York

    Google Scholar 

  • Royal College of General Practitioners (1978): Oral Contraceptive Study: Oral Contraceptives, venous thrombosis and varicose veins. Journal of the Royal College of General Practitioners 28: 393–399

    Google Scholar 

  • Royal College of General Practitioners’ Oral Contraceptive Study (1977): Mortality among oral contraceptive users. Lancet II 727–731

    Google Scholar 

  • Royal College of General Practitioners Oral Contraceptive Study (1981): Further analyses of mortality in oral contraceptive users. Lancet 541–546

    Google Scholar 

  • Runnebaum B, Rabe T (1982): Risiko-Nutzen-Analyse der hormonalen Kontrazeption. Deutsches Ärzteblatt 79: 29–48

    Google Scholar 

  • Shapiro S, Slone D, Rosenberg L, Kaufman DW, Stolley PD, Miettinen OS (1979): Oral-contraceptive use in relation to myocardial infarction. Lancet I 743–747

    Article  Google Scholar 

  • Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD (1981): Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. New England J Med 305:420–424

    Article  CAS  Google Scholar 

  • Sturtevant FM (1979): Oral contraceptives and liver tumors, in: Controversies in Contraception. KS Moghissi (Hrsg.), The Williams & Wilkins Company, Baltimore 93–150

    Google Scholar 

  • Tietze CH, Lewit S (1977/1978): Mortality and Fertility Control. Int J Gynaecol Obstet 15: 100 and 16:456–459

    PubMed  CAS  Google Scholar 

  • Vessey M, Doll R, Johnson B, Wiggins P (1976): A long-term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 8: 375–427

    Article  Google Scholar 

  • Vessey MP, McPherson K, Johnson B (1977): Moratility among women participating in the Oxford/Family Planning Association contraceptive study. Lancet II 731–733

    Article  Google Scholar 

  • Vessey MP, Kay CR, Baldwin JA, Clarke B, MacLeod IB (1977): Oral contraceptives and benign liver tumours. Brit Med J II 1064

    Article  Google Scholar 

  • Wingrave SJ (1982): Progestogen effects and their relationship to lipoprotein Changes. Acta Obstet Gynecol Scand Suppl. 105: 33–36

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. für Gynäkologische Endokrinologie, Universitäts-Frauenklinik Heidelberg, Voßstraße 9, 6900, Heidelberg, Germany

    Prof. Dr. B. Runnebaum

Authors
  1. Prof. Dr. B. Runnebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Rabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für gynäkologische Endokrinologie, Universitäts-Frauenklinik Heidelberg, Voßstraße 9, 6900, Heidelberg, Germany

    Benno Runnebaum  & Thomas Rabe  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Runnebaum, B., Rabe, T. (1985). Risikoanalyse der hormonalen Kontrazeption. In: Runnebaum, B., Rabe, T. (eds) Hormonale Kontrazeption. Steinkopff. https://doi.org/10.1007/978-3-642-85340-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85340-1_1

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0646-6

  • Online ISBN: 978-3-642-85340-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation